TY - JOUR PY - 2014// TI - A novel in-vitro model of human aortic valve mineralization JO - Journal of heart valve disease A1 - Goncerz, G. A1 - Tomaszewski, K.A. A1 - Pasternak, A. A1 - Głowacki, R. A1 - Wróbel, A. A1 - Rokita, E. A1 - Podolec, P. SP - 545 EP - 549 VL - 23 IS - 5 N2 - BACKGROUND AND AIM OF THE STUDY: The study aim was to develop an in-vitro model of human aortic valve homograft (AVH) mineralization, as a basis for further research on the subject of calcific aortic valve disease (CAVD).; METHODS: Human aortic valves were excised during autopsy (12-24 h post-mortem) from donors who had died due to accident or suicide. The mean (±SD) donor age was 32.5 ± 11.4 years. Under sterile conditions each aortic cusp (three cusps per valve) was cut in half to provide a total of 240 tissue samples. AVH mineralization was assessed in solutions with different Ca and P concentrations and CaxPO4 ionic product values. The impact of time on aortic valve mineralization rate was assessed using energy-dispersive X-ray fluorescence (ED-XRF).; RESULTS: The model showed that human AVH mineralization can be best observed in a solution with a CaxPO4 ionic product of 2.2 mmol2/l2. The optimum incubation time for observing AVH mineralization was 21 days.; CONCLUSION: A novel in-vitro AVH mineralization model was developed for use in future studies.

Language: en

LA - en SN - 0966-8519 UR - http://dx.doi.org/ ID - ref1 ER -